Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open Β· NYSEΒ·NewsletterΒ·MastheadΒ·
VOL. XII Β· NO. 117Established MMXIV Β· George Town, Grand CaymanAtlantic Edition Β· $4.50

The Cayman Journal

Finance Β· Business Β· Technology Β· Caribbean & Global Affairs
Markets Β· Healthcare

KZR (KZR)

Biotechnology

Sources: Yahoo Finance (quote, statistics) Β· SEC EDGAR (filings, insider trades, 13F holders) Β· company filings & press wires

Market Cap
β€”
P/E (TTM)
β€”
EPS
β€”
Div Yield
β€”
52W Range
β€”
Beta
β€”

Company overview

Live quote temporarily unavailable β€” press releases and news are still shown below.

No company overview is available for KZR yet.

Peers in Biotechnology

All in industry β†’

Recent press releases

March 2026

4 months ago8-KHealthcare

Kezar Life Sciences, Inc. β€” 8-K Filing

KZRKezar Life Sciences, Inc.

# 🧾 What This Document Is This is an **SEC Form 8-K filing** from Kezar Life Sciences. It contains the official legal contracts for a major corporate event: **Kezar is being acquired by Aurinia Pharma.** Think of it like the final paperwork you sign when selling a house. It doesn't just say "we'r

Read summaryView on SEC EDGAR
1 recent filing shown in the timeline above. View all SEC filings β†’

KZR has no reported insider trades in the last 90 days.

Institutional holders

All holders β†’
As of 2025-09-30 Β· prior 2025-06-30
157,286 sh● NEW

People at KZR

All people β†’

Quarterly financials

Full financials β†’
Revenue trend
03/25
β€”
NI -$16.6M
06/25
β€”
NI -$13.7M
09/25
β€”
NI -$11.2M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-1.53
Prior: $-1.87
Revenue sparkline